title: Combined modality therapy of stage IIIC breast cancer.
authors.forename: Rodrigo
authors.initials: R
authors.lastname: Dienstmann
authors.forename: Luís Guilherme
authors.initials: LG
authors.lastname: Branco
authors.forename: Lígia M
authors.initials: LM
authors.lastname: Rezende
authors.forename: Leila C
authors.initials: LC
authors.lastname: Freitas
authors.forename: Carlos Frederico
authors.initials: CF
authors.lastname: Lima
authors.forename: Guilherme J
authors.initials: GJ
authors.lastname: Rodrigues
authors.forename: Hélio
authors.initials: H
authors.lastname: Noronha Filho
authors.forename: Roberta B
authors.initials: RB
authors.lastname: Sarmento
authors.forename: Isabele
authors.initials: I
authors.lastname: Small
authors.forename: José
authors.initials: J
authors.lastname: Bines
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D008207:Lymphatic Metastasis; D008408:Mastectomy; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D011446:Prospective Studies
chemical_list: D000970:Antineoplastic Agents